0001209191-12-040030.txt : 20120802
0001209191-12-040030.hdr.sgml : 20120802
20120802154447
ACCESSION NUMBER: 0001209191-12-040030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120801
FILED AS OF DATE: 20120802
DATE AS OF CHANGE: 20120802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 121003348
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2012-08-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2012-08-01
4
M
0
4000
15.60
A
636895
D
Common Stock
2012-08-01
4
S
0
2800
49.09
D
634095
D
Common Stock
2012-08-01
4
S
0
1200
49.80
D
632895
D
Common Stock
13286
I
401(k)
Common Stock
300000
I
Common Stock held in trust.
Employee Stock Option (right to buy)
15.60
2012-08-01
4
M
0
4000
0.00
D
2013-01-17
Common Stock
4000
86951
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $49.09 (range $48.38 to $49.36).
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $49.80 (range $49.39 to $50.14).
Common stock held in grantor retained annuity trusts.
Fully vested.
Valerie L. Andrews, Attorney-In-Fact
2012-08-02